Financial reports
20-F/A
2022 FY
Annual report (foreign) (amended)
31 Oct 23
20-F
2022 FY
Annual report (foreign)
14 Mar 23
20-F
2021 FY
Annual report (foreign)
3 Mar 22
20-F
2020 FY
Annual report (foreign)
4 Mar 21
20-F
2019 FY
Annual report (foreign)
5 Mar 20
20-F/A
2018 FY
Annual report (foreign) (amended)
25 Apr 19
20-F
2018 FY
Annual report (foreign)
11 Mar 19
20-F
2017 FY
Annual report (foreign)
13 Mar 18
20-F
2016 FY
Annual report (foreign)
23 Mar 17
20-F
2015 FY
Annual report (foreign)
21 Mar 16
Current reports
6-K
Current report (foreign)
16 Jan 24
6-K
Current report (foreign)
22 Dec 23
6-K
Current report (foreign)
22 Dec 23
6-K
Current report (foreign)
5 Dec 23
6-K
Current report (foreign)
17 Nov 23
6-K
Current report (foreign)
17 Nov 23
6-K
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
15 Nov 23
6-K
Joint Researchand Collaboration Agreement
9 Nov 23
6-K
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
6 Nov 23
6-K
Current report (foreign)
6 Nov 23
Registration and prospectus
S-8
Registration of securities for employees
7 Aug 23
424B5
Prospectus supplement for primary offering
3 Feb 23
424B5
Prospectus supplement for primary offering
2 Feb 23
FWP
Free writing prospectus
4 Jan 23
424B5
Prospectus supplement for primary offering
4 Jan 23
S-8
Registration of securities for employees
6 Oct 22
F-3
Shelf registration (foreign)
24 Jun 22
POSASR
Automatic shelf registration (post-effective amendment)
24 Jun 22
S-8 POS
Registration of securities for employees (post-effective amendment)
3 Mar 22
S-8
Registration of securities for employees
5 Aug 21
Proxies
No filings
Other
EFFECT
Notice of effectiveness
8 Jul 22
CORRESP
Correspondence with SEC
5 Jul 22
UPLOAD
Letter from SEC
29 Jun 22
CT ORDER
Confidential treatment order
29 Dec 20
CT ORDER
Confidential treatment order
5 Apr 18
UPLOAD
Letter from SEC
28 Nov 17
CORRESP
Correspondence with SEC
14 Nov 17
UPLOAD
Letter from SEC
31 Oct 17
CORRESP
Correspondence with SEC
10 Oct 17
CORRESP
Correspondence with SEC
25 Sep 17
Ownership
SC 13G/A
Long Focus Capital Management, LLC
14 Feb 24
SC 13G/A
PFIZER INC
14 Feb 24
SC 13G/A
BAILLIE GIFFORD & CO
5 Dec 23
SC 13D/A
ASTRAZENECA PLC
16 Nov 23
SC 13D/A
Bpifrance Participations SA
13 Nov 23
SC 13D
ASTRAZENECA PLC
9 Nov 23
SC 13D/A
Cibus, Inc.
1 Jun 23
SC 13G/A
Long Focus Capital Management, LLC
14 Feb 23
SC 13D/A
Bpifrance Participations SA
14 Feb 23
SC 13G/A
BAILLIE GIFFORD & CO
18 Jan 23